"Debulking" the future of lymphedema surgery: A narrative review

To summarize and contextualize current and future perspectives in the surgical treatment of lymphedema, exploring new techniques and technologies, integrated treatment modalities, and their real-time clinical applications.

Lymphedema is a debilitating condition caused by impaired lymphatic flow. It diminishes quality of life (QoL) and often leads to other sequential comorbidities. There is no established cure, and the optimal treatment option remains debated. Understanding current and future surgical approaches, especially the preventive and curative role at early stages, would be valuable.

A literature review was conducted using PubMed, Cochrane, and Google Scholar, including only high-impact systematic reviews, meta-analyses, and randomized controlled trials from the past 10 years.

Lymphovenous anastomosis, vascularized lymph node transfer, and liposuction were among the most discussed surgical treatment options. Benefits include speedy volume reduction, greater QoL, and better wound healing. Microsurgical techniques greatly aided early-stage lymphedema. Fibrotic, irreversible lymphedema cases were better treated with reductive procedures and improved QoL. On the flip side, we are encountering limitations in standardization, resources, and the need for adjunctive conservative therapy while trying to make surgical treatment the mainstay. Technological advances like imaging and robotics, and future innovations like regenerative medicine show potential, but further high-quality, long-term studies are necessary for standardized, cost-effective, and widely accessible care.

Modern surgical treatment for lymphedema offers safer, more effective, and more individualized solutions. To make these procedures a part of mainstream, multidisciplinary care, further development must go into training, standardizing protocols, and making them accessible.